Busky Joseph M. 4

What Happened

• Joseph M. Busky, Chief Financial Officer of QuidelOrtho Corporation (QDEL), received a grant of 29,444 restricted stock units (RSUs) on January 30, 2026. The award is reported as 29,444 shares at $0.00 per share (derivative/award transaction code A). No cash purchase or sale occurred — this is a compensation award, not an open-market trade.

Key Details

• Transaction date: January 30, 2026; Form 4 filed February 3, 2026 (timely — within required two business days).
• Reported amount: 29,444 RSUs @ $0.00 (derivative award, code A).
• Shares owned after transaction: not specified in the provided excerpt of the filing.
• Footnotes: F1 — each RSU converts to one share of QuidelOrtho common stock; F2 — vesting schedule: 9,814 shares vest on Jan 30, 2027; the remaining 19,630 vest in equal installments on Jan 30, 2028 and Jan 30, 2029.
• No 10b5-1 plan, tax-withholding, or late-filing flag is noted in the provided information.

Context

• RSU grants are a form of equity compensation that convert to actual shares only as they vest; they do not indicate an immediate purchase or sale by the insider. Such awards are commonly part of executive compensation and should be interpreted as remuneration rather than a direct trading signal.